HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.

Abstract
The antitumor and metastasis-inhibitory activities, mode of action, and clinical application of lentinan, a strictly purified beta-1,6:beta-1,3-glucan, are reviewed. Lentinan exerts a prominent antitumor effect and prevents chemical and viral oncogenesis. The antitumor action of lentinan is host-mediated. Compared to other well-known immunostimulants, such as bacille Calmette Guérin (BCG), Corynebacterium parvum, and lipopolysaccharide (LPS), lentinan appears to represent a unique class of immunopotentiator, a T cell-oriented adjuvant. Lentinan triggers the increased production of various kinds of bioactive serum factors associated with immunity and inflammation, such as IL-1, CSF, IL-3, vascular dilation inducer, and acute-phase protein inducer, by the direct impact of macrophages or indirectly via lentinan-stimulated T cells, which results in the induction of many immunobiological changes in the host. Augmented IL-1 production amplifies the maturation of immature effector cells to mature cells capable of responding to lymphokines such as IL-2 and T cell-replacing factors. Because of this mode of action, intact T cell compartments for antitumor activity of lentinan are required. Lentinan has little toxic side effects. Excellent results were obtained in a 4 year follow-up of the randomized control study of lentinan in phase III on patients with advanced and recurrent stomach and colorectal cancer.
AuthorsG Chihara, J Hamuro, Y Y Maeda, T Shiio, T Suga, N Takasuka, T Sasaki
JournalCancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc (Cancer Detect Prev Suppl) Vol. 1 Pg. 423-43 ( 1987) ISSN: 1043-6995 [Print] United States
PMID3319150 (Publication Type: Journal Article, Review)
Chemical References
  • Adjuvants, Immunologic
  • Antineoplastic Agents
  • Polysaccharides
  • Lentinan
Topics
  • Adjuvants, Immunologic
  • Animals
  • Antineoplastic Agents
  • Immunotherapy
  • Lentinan (therapeutic use)
  • Neoplasm Metastasis (prevention & control)
  • Neoplasms, Experimental (pathology, therapy)
  • Polysaccharides (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: